Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


VINCENT RICHARD G Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 VINCENT RICHARD G (CFO) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns: Disposed/sold 75,000 options @ $5.76, valued at $432k
Disposed/sold 35,120 options @ $3.33, valued at $116.9k
Disposed/sold 280,000 options @ $7.05, valued at $2M
Disposed/sold 109,579 options @ $1.94, valued at $212.6k
Disposed/sold 28,750 options @ $1.04, valued at $29.9k
Disposed/sold 210,000 options @ $0.96, valued at $201.6k
Granted 75,000 options @ $0
Granted 35,120 options @ $0
Granted 280,000 options @ $0
Granted 109,597 options @ $0
Granted 28,750 options @ $0
07/05/2023 4 VINCENT RICHARD G (CFO) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns: Paid exercise price by delivering 7,069 shares @ $0.36, valued at $2.5k
04/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/23/2023 4 VINCENT RICHARD G (CFO) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns: Granted 210,000 options @ $0.96, valued at $201.6k
01/05/2023 4 VINCENT RICHARD G (CFO) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns: Paid exercise price by delivering 4,428 shares @ $1.02, valued at $4.5k
08/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/28/2022 4 VINCENT RICHARD G (CFO) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns: Bought 3 shares @ $1.45, valued at $4.4
Bought 356 shares @ $1.45, valued at $516.2
Bought 5 shares @ $1.48, valued at $7.4
Bought 2,136 shares @ $1.4899, valued at $3.2k
Bought 2,500 shares @ $1.4, valued at $3.5k
01/31/2022 4 VINCENT RICHARD G (CFO) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns: Bought 5,000 shares @ $1.8, valued at $9k
Bought 5,000 shares @ $1.7, valued at $8.5k
Bought 2,500 shares @ $1.65, valued at $4.1k
01/24/2022 4 VINCENT RICHARD G (CFO) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns: Granted 109,579 options @ $1.94, valued at $212.6k
01/05/2022 4 VINCENT RICHARD G (CFO) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns: Granted 29,867 shares @ $0
02/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/31/2020 4/A VINCENT RICHARD G (CFO) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns: Granted 35,120 options to buy @ $3.33, valued at $116.9k
07/31/2020 4/A VINCENT RICHARD G (CFO) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns: Granted 75,000 options @ $5.76, valued at $432k
03/18/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/16/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/11/2019 4 VINCENT RICHARD G (CFO) has filed a Form 4 on GTX INC /DE/
Txns: Granted 42,628 shares @ $0
Granted 4,526 shares @ $0
Granted 1,834 shares @ $0
Granted 73,385 options @ $0.81, valued at $59.4k
Granted 281 warrants @ $6.13, valued at $1.7k
06/11/2019 3 VINCENT RICHARD G (CFO) has filed a Form 3 on GTX INC /DE/
10/09/2014 4 VINCENT RICHARD G (See Remarks) has filed a Form 4 on Sorrento Therapeutics, Inc.
Txns: Granted 50,000 options @ $4.32, valued at $216k
10/31/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
10/19/2012 4 VINCENT RICHARD G (CFO) has filed a Form 4 on Sorrento Therapeutics, Inc.
Txns: Disposed/sold 725,000 options to buy @ $0.16, valued at $116k
10/19/2012 4 VINCENT RICHARD G (CFO) has filed a Form 4 on Sorrento Therapeutics, Inc.
Txns: Disposed/sold 725,000 options to buy @ $0.16, valued at $116k
09/25/2012 4 VINCENT RICHARD G (CFO) has filed a Form 4 on Sorrento Therapeutics, Inc.
Txns: Granted 3,000,000 options to buy @ $0.16, valued at $480k
03/09/2011 4 Form 4 - Statement of changes in beneficial ownership of securities
02/09/2010 4 VINCENT RICHARD G (CFO) has filed a Form 4 on Sorrento Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $0.07, valued at $7k
02/09/2010 3 VINCENT RICHARD G (CFO) has filed a Form 3 on Sorrento Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy